|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Chinese University of Hong Kong |
| Information provided by: | Chinese University of Hong Kong |
| ClinicalTrials.gov Identifier: | NCT00456755 |
Purpose
Allergic rhinitis(AR) is one of the most common allergic disorders throughout the world.The conventional therapies are effective in alleviating symptoms but the efficacy are limited and not persistent. Furthermonre, the cost and side-effect are known defects. A classical Chinese herbal formula, has been used for AR for centries. Our study purpose is to evaluate the clinical efficacy and safety of this formula verus placebo in perennial allergic rhinitis (PAR).
Hypothesis: the classical herbal formula would improve the symptoms of PAR patients and change some immunological parameters in the peripheral blood when comparing with the placebo.
| Condition | Intervention | Phase |
|
Perennial Allergic Rhinitis |
Drug: Cang Er Zhi San Plus |
Phase II |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
| Official Title: | A Herbal Formula (SBL) for the Treatment of Perennial Allergic Rhinitis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial |
| Estimated Enrollment: | 126 |
| Study Start Date: | March 2004 |
| Study Completion Date: | April 2006 |
It is a randomized, double-blind, placebo-controlled trial.
Eligibility
| Ages Eligible for Study: | 18 Years to 65 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Hong Kong | |||||
| Department of ENT, Prince of Wales Hospital | |||||
| Hong Kong, Hong Kong | |||||
| Department of ENT, Yan Chai Hospital | |||||
| Hong Kong, Hong Kong | |||||
| Chinese University of Hong Kong |
| Principal Investigator: | Zhao Yu, PhD | Department of ENT, Prince of Wales Hospital, The Chinese University of Hong Kong |
More Information
| Study ID Numbers: | ICM/CTS/03/333 |
| First Received: | April 4, 2007 |
| Last Updated: | April 4, 2007 |
| ClinicalTrials.gov Identifier: | NCT00456755 |
| Health Authority: | Hong Kong: Joint CUHK-NTEC Clinical Research Ethics Committee |
|
|
|
|